Literature DB >> 282045

A renal carcinoma secreting inactive renin.

B Leckie, J J Brown, R Fraser, K Kyle, A F Lever, J J Morton, J I Robertson.   

Abstract

1. A patient presented with mild hypertension, a raised plasma total renin concentration but a normal plasma angiotensin II concentration. The discrepancy was due to a high concentration of inactive renin in the plasma. 2. A renal carcinoma was detected and removed. The tumour contained a higher proportion of inactive renin than was found in uninvolved areas of the kidney. After unilateral nephrectomy, the plasma concentration of inactive renin fell to normal. 3. Six months later, plasma inactive renin concentration again increased and a metastasis was detected in a rib. Excision of the rib together with radiotherapy resulted in a fall in plasma inactive renin to normal. 4. The inactive renin in plasma and tumour extracts was activated to the same extent by acid treatment and by trypsin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282045     DOI: 10.1042/cs055159s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  4 in total

1.  An ultrastructural and immunocytochemical study of a renal carcinoma secreting inactive renin.

Authors:  G B Lindop; I A More; B Leckie
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

2.  Renin-producing renal cell carcinomas--clinical and experimental investigations on a special form of renal hypertension.

Authors:  J Steffens; R Bock; H U Braedel; E Isenberg; C P Bührle; M Ziegler
Journal:  Urol Res       Date:  1992

3.  Renin in renal cell carcinoma--an immunocytochemical study using an antibody to pure human renin.

Authors:  G B Lindop; S Fleming
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

4.  Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study.

Authors:  G M Taylor; H T Cook; E A Sheffield; C Hanson; W S Peart
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.